475
Participants
Start Date
December 10, 2024
Primary Completion Date
May 23, 2027
Study Completion Date
May 23, 2028
biolimus-coated balloon
238 subjects with de novo large vessel coronary lesions who met the inclusion/exclusion criteria were enrolled; subjects were assigned to the treatment group of Biolimus-coated balloon.
paclitaxel-coated balloon
237 subjects with de novo large vessel coronary lesions who met the inclusion/exclusion criteria were enrolled; subjects were assigned to the treatment group of paclitaxel-coated balloon.
Xuzhou Third People's Hospital
OTHER